IDARUCIZUMAB

IDARUCIZUMAB was reported 1434 times

IDARUCIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LIMB GIRTH INCREASED 1 0.1250
1 CRANIOFACIAL INJURY 1 0.0833
2 COAGULATION FACTOR INCREASED 5 0.0820
3 THROMBIN TIME ABNORMAL 3 0.0667
4 PERIPROCEDURAL MYOCARDIAL INFARCTION 1 0.0385
5 DECOMPRESSIVE CRANIECTOMY 1 0.0357
6 ANTICOAGULATION DRUG LEVEL INCREASED 11 0.0343
7 SPLEEN SCAN ABNORMAL 1 0.0303
8 BASILAR ARTERY ANEURYSM 1 0.0303
9 BASILAR ARTERY OCCLUSION 5 0.0301
10 PROCEDURAL SHOCK 1 0.0278
11 THROMBIN TIME PROLONGED 6 0.0243
12 BASAL GANGLIA HAEMATOMA 1 0.0238
13 URACHAL ABNORMALITY 1 0.0222
14 CORONARY BYPASS THROMBOSIS 1 0.0213
15 POSTOPERATIVE RESPIRATORY FAILURE 2 0.0192
16 STROKE IN EVOLUTION 4 0.0180
17 HAEMORRHAGIC TRANSFORMATION STROKE 26 0.0173
18 CEREBRAL DYSGENESIS 1 0.0167
19 QUADRANTANOPIA 2 0.0153
20 BROWN-SEQUARD SYNDROME 1 0.0147
21 HAEMORRHAGE CORONARY ARTERY 1 0.0139
22 INTERVENTIONAL PROCEDURE 1 0.0135
23 ANTICOAGULATION DRUG LEVEL ABNORMAL 2 0.0134
24 VERTEBRAL ARTERY OCCLUSION 3 0.0133
25 CARDIAC CONTRACTILITY DECREASED 1 0.0130
26 HYPERALBUMINAEMIA 1 0.0122
27 NIH STROKE SCALE SCORE INCREASED 1 0.0120
28 COLONIC HAEMATOMA 1 0.0118
29 MESENTERIC HAEMORRHAGE 1 0.0116
30 SCROTAL HAEMATOMA 1 0.0105
31 RECTAL PERFORATION 5 0.0093
32 COAGULATION TIME PROLONGED 14 0.0090
33 POST PROCEDURAL URINE LEAK 1 0.0090
34 PULMONARY RENAL SYNDROME 3 0.0086
35 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 2 0.0081
36 GENITAL NEOPLASM MALIGNANT FEMALE 1 0.0081
37 HAEMORRHAGIC CHOLECYSTITIS 1 0.0080
38 SPINAL SUBDURAL HAEMATOMA 1 0.0077
39 SUBARACHNOID HAEMATOMA 1 0.0075
40 SPINDLE CELL SARCOMA 1 0.0074
41 BRONCHIAL NEOPLASM 1 0.0074
42 TRAUMATIC HAEMOTHORAX 2 0.0072
43 HAEMORRHAGIC CEREBRAL INFARCTION 5 0.0071
44 BASAL GANGLIA STROKE 1 0.0069
45 POST PROCEDURAL PNEUMONIA 2 0.0067
46 PANCREATIC INJURY 2 0.0066
47 LACUNAR STROKE 2 0.0063
48 INTESTINAL STRANGULATION 1 0.0062
49 HAEMOSTASIS 1 0.0061
50 PROSTATIC OBSTRUCTION 1 0.0060
51 VASCULAR PROCEDURE COMPLICATION 1 0.0058
52 CONJUNCTIVAL PALLOR 1 0.0055
53 HAEMORRHAGIC DISORDER 6 0.0055
54 BRAIN CONTUSION 4 0.0055
55 HAEMORRHAGIC INFARCTION 3 0.0055
56 ANEURYSM RUPTURED 5 0.0055
57 NEUROSURGERY 1 0.0054
58 PROCOAGULANT THERAPY 4 0.0053
59 ANASTOMOTIC HAEMORRHAGE 1 0.0053
60 SHOCK HAEMORRHAGIC 41 0.0050
61 SUBCAPSULAR RENAL HAEMATOMA 1 0.0047
62 COMPLICATIONS OF TRANSPLANTED HEART 1 0.0047
63 RENAL NECROSIS 1 0.0046
64 PELVIC HAEMATOMA 2 0.0045
65 HAEMORRHAGE INTRACRANIAL 67 0.0045
66 HEPATIC RUPTURE 1 0.0045
67 RESPIRATORY FATIGUE 1 0.0043
68 PERICARDIAL HAEMORRHAGE 9 0.0041
69 VESSEL PUNCTURE SITE HAEMORRHAGE 1 0.0041
70 COAGULATION TEST ABNORMAL 3 0.0039
71 CEREBRAL ARTERY THROMBOSIS 2 0.0039
72 GASTROINTESTINAL LYMPHOMA 1 0.0038
73 EYE HAEMATOMA 1 0.0038
74 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 4 0.0036
75 CEREBELLAR HAEMATOMA 1 0.0036
76 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 18 0.0036
77 VASCULAR ENCEPHALOPATHY 1 0.0035
78 MUCOSAL HAEMORRHAGE 4 0.0034
79 BLEEDING TIME PROLONGED 4 0.0033
80 MYOCARDIAL RUPTURE 1 0.0033
81 TRAUMATIC INTRACRANIAL HAEMORRHAGE 3 0.0033
82 PRODUCT APPEARANCE CONFUSION 3 0.0032
83 POST PROCEDURAL BILE LEAK 1 0.0032
84 FEMORAL ARTERY OCCLUSION 1 0.0032
85 AORTIC DISSECTION 13 0.0031
86 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 1 0.0031
87 THROMBECTOMY 1 0.0031
88 PROCEDURAL HAEMORRHAGE 12 0.0031
89 PACKAGING DESIGN ISSUE 1 0.0030
90 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 2 0.0030
91 COAGULATION TIME SHORTENED 1 0.0030
92 LOW CARDIAC OUTPUT SYNDROME 1 0.0030
93 PNEUMONIA ESCHERICHIA 1 0.0029
94 ANASTOMOTIC COMPLICATION 1 0.0029
95 METASTATIC CARCINOMA OF THE BLADDER 1 0.0028
96 HYPOVOLAEMIC SHOCK 13 0.0027
97 SOFT TISSUE HAEMORRHAGE 1 0.0027
98 LUMBAR PUNCTURE 1 0.0026
99 ARTERIAL HAEMORRHAGE 3 0.0026
100 NEUROLOGICAL DECOMPENSATION 6 0.0026
101 ISCHAEMIC STROKE 45 0.0025
102 MULTIMORBIDITY 3 0.0025
103 VASCULAR STENT OCCLUSION 1 0.0025
104 VIRAL RASH 1 0.0025
105 CRANIOTOMY 1 0.0024
106 INTRAVENTRICULAR HAEMORRHAGE 6 0.0024
107 CEREBRAL HAEMATOMA 8 0.0024
108 CAROTID ARTERY THROMBOSIS 2 0.0024
109 CAROTID ARTERY DISSECTION 1 0.0023
110 FACIAL NERVE DISORDER 1 0.0023
111 CEREBRAL HAEMORRHAGE 80 0.0022
112 THERAPEUTIC PRODUCT EFFECT PROLONGED 1 0.0022
113 SUBDURAL HAEMORRHAGE 6 0.0022
114 MULTIPLE ORGAN DYSFUNCTION SYNDROME 62 0.0022
115 GALLBLADDER RUPTURE 1 0.0022
116 BILIARY SEPSIS 1 0.0022
117 PANCREATITIS HAEMORRHAGIC 1 0.0022
118 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0021
119 INTRACRANIAL MASS 2 0.0021
120 HEPATIC HAEMATOMA 1 0.0021
121 CARDIAC VALVE VEGETATION 1 0.0021
122 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 5 0.0020
123 OESOPHAGEAL ULCER HAEMORRHAGE 1 0.0020
124 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 3 0.0020
125 PLASMAPHERESIS 1 0.0019
126 BRAIN MIDLINE SHIFT 1 0.0019
127 CEREBRAL ARTERY OCCLUSION 2 0.0019
128 COAGULOPATHY 31 0.0019
129 LEFT ATRIAL ENLARGEMENT 1 0.0019
130 NEUROGENIC SHOCK 1 0.0018
131 QUADRIPARESIS 3 0.0018
132 INTRACRANIAL HAEMATOMA 1 0.0018
133 POSTOPERATIVE ILEUS 1 0.0018
134 NASAL MUCOSAL DISORDER 1 0.0017
135 RECTAL ULCER 2 0.0017
136 SPINAL EPIDURAL HAEMATOMA 1 0.0017
137 THALAMIC INFARCTION 1 0.0017
138 RESPIRATORY TRACT HAEMORRHAGE 1 0.0017
139 MONOPARESIS 3 0.0017
140 SUPERIOR VENA CAVA SYNDROME 1 0.0017
141 URETHRAL HAEMORRHAGE 1 0.0017
142 PUPILLARY DISORDER 1 0.0016
143 CARDIOGENIC SHOCK 23 0.0016
144 CORTISOL INCREASED 1 0.0016
145 TRAUMATIC HAEMORRHAGE 3 0.0016
146 METASTASES TO PELVIS 1 0.0016
147 ILEUS PARALYTIC 7 0.0016
148 RUPTURED CEREBRAL ANEURYSM 1 0.0015
149 POST PROCEDURAL HAEMORRHAGE 18 0.0015
150 PERITONEAL DISORDER 1 0.0015
151 CARDIOPULMONARY FAILURE 6 0.0015
152 DISEASE COMPLICATION 7 0.0015
153 ISCHAEMIA 7 0.0015
154 EXTRADURAL HAEMATOMA 2 0.0015
155 POST PROCEDURAL SEPSIS 1 0.0015
156 CARDIAC TAMPONADE 7 0.0015
157 PUNCTURE SITE HAEMORRHAGE 1 0.0014
158 PULMONARY SEPSIS 2 0.0014
159 GASTROINTESTINAL NECROSIS 4 0.0014
160 HEMIANOPIA HOMONYMOUS 1 0.0014
161 THROMBOTIC STROKE 1 0.0014
162 ARTERIAL INJURY 1 0.0013
163 BRAIN HERNIATION 4 0.0013
164 BRAIN STEM SYNDROME 1 0.0013
165 REBOUND EFFECT 15 0.0013
166 HAEMORRHAGIC STROKE 10 0.0013
167 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
168 HAPTOGLOBIN DECREASED 1 0.0012
169 PERFORATION 1 0.0012
170 SIMPLE PARTIAL SEIZURES 1 0.0012
171 ENTEROCOCCAL SEPSIS 1 0.0012
172 BASAL GANGLIA HAEMORRHAGE 1 0.0012
173 CARDIOVASCULAR INSUFFICIENCY 2 0.0012
174 CATHETER SITE HAEMORRHAGE 3 0.0012
175 BRAIN OEDEMA 15 0.0012
176 CEREBRAL INFARCTION 29 0.0012
177 SUBARACHNOID HAEMORRHAGE 12 0.0012
178 PROTHROMBIN TIME PROLONGED 7 0.0012
179 VITAL FUNCTIONS ABNORMAL 1 0.0012
180 HEPATIC CANCER METASTATIC 1 0.0012
181 CEREBRAL ISCHAEMIA 6 0.0012
182 THALAMUS HAEMORRHAGE 1 0.0011
183 CAROTID ARTERY STENOSIS 4 0.0011
184 HAEMORRHAGE 119 0.0011
185 ABDOMINAL SEPSIS 1 0.0011
186 EMBOLIC STROKE 4 0.0011
187 MELAENA 25 0.0011
188 CARDIAC OUTPUT DECREASED 1 0.0011
189 INTESTINAL INFARCTION 1 0.0011
190 INTESTINAL ISCHAEMIA 6 0.0011
191 VASOSPASM 1 0.0011
192 VENOUS INJURY 1 0.0011
193 ADENOCARCINOMA OF COLON 2 0.0011
194 MICROANGIOPATHY 1 0.0011
195 DUODENAL ULCER HAEMORRHAGE 3 0.0010
196 SUBDURAL HAEMATOMA 15 0.0010
197 SHOCK 24 0.0010
198 DISCOLOURED VOMIT 1 0.0010
199 BLOOD URINE 1 0.0010
200 HAEMOTHORAX 3 0.0010
201 PRODUCT LABEL CONFUSION 6 0.0010
202 DEVICE RELATED THROMBOSIS 1 0.0010
203 HYPOFIBRINOGENAEMIA 1 0.0010
204 BLADDER CANCER RECURRENT 1 0.0010
205 PRODUCT MEASURED POTENCY ISSUE 1 0.0010
206 SMALL INTESTINAL HAEMORRHAGE 2 0.0010
207 RENAL HAEMORRHAGE 2 0.0010
208 BRAIN STEM INFARCTION 1 0.0010
209 GASTROINTESTINAL HAEMORRHAGE 81 0.0010
210 CHEST INJURY 2 0.0010
211 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
212 HEMIPARESIS 16 0.0009
213 VASCULAR CALCIFICATION 1 0.0009
214 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
215 HAEMODYNAMIC INSTABILITY 7 0.0009
216 PRODUCT NAME CONFUSION 1 0.0009
217 PNEUMONIA STREPTOCOCCAL 1 0.0009
218 NOSOCOMIAL INFECTION 2 0.0009
219 TINEA INFECTION 1 0.0009
220 PELVIC ABSCESS 1 0.0009
221 PERIPHERAL EMBOLISM 1 0.0009
222 AORTIC THROMBOSIS 1 0.0009
223 HAEMATOMA 22 0.0008
224 CARDIAC DEATH 1 0.0008
225 SUBCUTANEOUS HAEMATOMA 1 0.0008
226 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
227 BILIARY OBSTRUCTION 1 0.0008
228 ANAEMIA POSTOPERATIVE 1 0.0008
229 SEPTIC SHOCK 33 0.0008
230 ACUTE CORONARY SYNDROME 6 0.0007
231 INTRACRANIAL PRESSURE INCREASED 4 0.0007
232 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
233 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
234 PRERENAL FAILURE 1 0.0007
235 CEREBELLAR HAEMORRHAGE 1 0.0007
236 HYPOVOLAEMIA 4 0.0007
237 CHOLANGIOCARCINOMA 1 0.0007
238 GASTRITIS HAEMORRHAGIC 1 0.0007
239 APHASIA 20 0.0007
240 CRANIOCEREBRAL INJURY 2 0.0007
241 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
242 MYELITIS 1 0.0006
243 MEGACOLON 1 0.0006
244 LIVER ABSCESS 2 0.0006
245 INTESTINAL POLYP 1 0.0006
246 SPINAL CORD DISORDER 1 0.0006
247 RESUSCITATION 1 0.0006
248 CARDIAC FAILURE ACUTE 4 0.0006
249 BRAIN INJURY 6 0.0006
250 HEPATORENAL SYNDROME 1 0.0006
251 CEREBELLAR INFARCTION 1 0.0006
252 CIRCULATORY COLLAPSE 10 0.0006
253 GAZE PALSY 1 0.0006
254 ANURIA 5 0.0006
255 BLOOD CREATININE ABNORMAL 2 0.0006
256 PUPIL FIXED 1 0.0006
257 VASCULAR PSEUDOANEURYSM 1 0.0006
258 SPLENIC INFARCTION 1 0.0006
259 GASTROINTESTINAL OEDEMA 1 0.0006
260 HAEMORRHAGIC DIATHESIS 2 0.0006
261 AORTIC VALVE STENOSIS 1 0.0006
262 CARDIAC ABLATION 1 0.0006
263 HAEMATEMESIS 14 0.0006
264 CEREBRAL VENOUS THROMBOSIS 1 0.0006
265 PNEUMONIA KLEBSIELLA 1 0.0005
266 UROSEPSIS 5 0.0005
267 PNEUMOPERITONEUM 1 0.0005
268 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
269 STENOSIS 1 0.0005
270 PERITONITIS 11 0.0005
271 HYPERCOAGULATION 1 0.0005
272 TONGUE OEDEMA 2 0.0005
273 TRAUMATIC LUNG INJURY 1 0.0005
274 ARTERIAL THROMBOSIS 1 0.0005
275 ABDOMINAL WALL HAEMATOMA 1 0.0005
276 AZOTAEMIA 2 0.0005
277 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
278 ANAPHYLACTOID REACTION 2 0.0005
279 VENOUS THROMBOSIS LIMB 1 0.0005
280 EMBOLISM 4 0.0005
281 HEMIPLEGIA 4 0.0005
282 PNEUMONIA ASPIRATION 12 0.0005
283 MULTIPLE INJURIES 3 0.0005
284 URINARY BLADDER HAEMORRHAGE 1 0.0005
285 HAEMATURIA 16 0.0005
286 METASTATIC NEOPLASM 2 0.0005
287 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
288 ENDOMETRIAL CANCER 1 0.0005
289 RETROPERITONEAL HAEMATOMA 1 0.0005
290 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
291 LARGE INTESTINAL OBSTRUCTION 1 0.0004
292 CALCINOSIS 1 0.0004
293 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
294 COLITIS ISCHAEMIC 3 0.0004
295 DISTRIBUTIVE SHOCK 1 0.0004
296 BLOOD LOSS ANAEMIA 1 0.0004
297 DRUG EFFECT DELAYED 2 0.0004
298 BRAIN OPERATION 1 0.0004
299 RIGHT VENTRICULAR FAILURE 3 0.0004
300 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
301 VOLVULUS 1 0.0004
302 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
303 RECTAL HAEMORRHAGE 18 0.0004
304 GUILLAIN-BARRE SYNDROME 2 0.0004
305 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
306 SEPSIS 46 0.0004
307 ACUTE MYOCARDIAL INFARCTION 12 0.0004
308 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
309 VENTRICULAR HYPERTROPHY 1 0.0004
310 HAEMORRHAGE URINARY TRACT 1 0.0004
311 ACIDOSIS 3 0.0004
312 PROCEDURAL COMPLICATION 3 0.0004
313 CARDIAC FAILURE 31 0.0004
314 PULMONARY HAEMORRHAGE 3 0.0004
315 LARGE INTESTINAL ULCER 1 0.0004
316 CLUMSINESS 1 0.0004
317 ASPIRATION 4 0.0004
318 CARDIAC ARREST 30 0.0004
319 CHOLECYSTITIS INFECTIVE 1 0.0004
320 ANAL HAEMORRHAGE 1 0.0004
321 PROCTITIS 1 0.0004
322 ENDOTRACHEAL INTUBATION 1 0.0004
323 NEUTROPHIL COUNT ABNORMAL 1 0.0004
324 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
325 CEREBRAL THROMBOSIS 1 0.0004
326 INTERNAL HAEMORRHAGE 4 0.0003
327 PARAPLEGIA 1 0.0003
328 COMA 16 0.0003
329 EYE INJURY 1 0.0003
330 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
331 INTRACARDIAC THROMBUS 1 0.0003
332 RECTAL CANCER 1 0.0003
333 LARYNGEAL OEDEMA 2 0.0003
334 BRAIN DEATH 1 0.0003
335 ACUTE KIDNEY INJURY 48 0.0003
336 POST PROCEDURAL COMPLICATION 6 0.0003
337 CUSHINGOID 1 0.0003
338 VENTRICULAR HYPOKINESIA 1 0.0003
339 PORTAL VEIN THROMBOSIS 1 0.0003
340 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
341 PEPTIC ULCER 1 0.0003
342 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
343 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
344 HEPATIC CYST 1 0.0003
345 B-CELL LYMPHOMA 1 0.0003
346 SUDDEN CARDIAC DEATH 1 0.0003
347 GINGIVAL BLEEDING 4 0.0003
348 LARGE INTESTINE PERFORATION 2 0.0003
349 RESPIRATORY FAILURE 21 0.0003
350 AORTIC STENOSIS 1 0.0003
351 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
352 CAROTID ARTERY OCCLUSION 1 0.0003
353 WOUND HAEMORRHAGE 1 0.0003
354 CEREBRAL DISORDER 2 0.0003
355 PRODUCT STORAGE ISSUE 1 0.0003
356 CARDIO-RESPIRATORY ARREST 11 0.0003
357 AORTIC ANEURYSM 2 0.0003
358 GASTRIC HAEMORRHAGE 3 0.0003
359 ACUTE RESPIRATORY FAILURE 5 0.0003
360 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
361 LUNG INFECTION 4 0.0003
362 SPINAL CORD COMPRESSION 1 0.0003
363 CERVIX CARCINOMA 1 0.0003
364 TRANSPLANT REJECTION 2 0.0002
365 BLOOD DISORDER 2 0.0002
366 ORGAN FAILURE 1 0.0002
367 PRODUCT ADMINISTRATION ERROR 5 0.0002
368 LACTIC ACIDOSIS 8 0.0002
369 ARTHRITIS BACTERIAL 1 0.0002
370 EXTRAVASATION 1 0.0002
371 HYPERPYREXIA 1 0.0002
372 LIP OEDEMA 1 0.0002
373 BUNDLE BRANCH BLOCK LEFT 1 0.0002
374 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
375 CARDIAC FAILURE CHRONIC 1 0.0002
376 PRODUCT DISPENSING ISSUE 1 0.0002
377 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
378 DIVERTICULUM INTESTINAL 1 0.0002
379 HAEMORRHAGIC ANAEMIA 1 0.0002
380 ABDOMINAL ABSCESS 1 0.0002
381 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
382 BRAIN NEOPLASM MALIGNANT 1 0.0002
383 TACHYPNOEA 3 0.0002
384 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
385 RENAL FAILURE 29 0.0002
386 PERICARDIAL EFFUSION 5 0.0002
387 MEDICATION ERROR 12 0.0002
388 GASTRITIS EROSIVE 1 0.0002
389 GENERAL PHYSICAL HEALTH DETERIORATION 24 0.0002
390 ENTEROCOCCAL INFECTION 1 0.0002
391 RENAL TUBULAR NECROSIS 2 0.0002
392 SKIN HAEMORRHAGE 3 0.0002
393 HYPERVOLAEMIA 1 0.0002
394 ABDOMINAL TENDERNESS 1 0.0002
395 ANEURYSM 1 0.0002
396 CEREBROVASCULAR ACCIDENT 34 0.0002
397 HYPERNATRAEMIA 1 0.0002
398 EPISTAXIS 15 0.0002
399 HAEMATOCHEZIA 11 0.0002
400 DEATH 170 0.0002
401 DRUG LEVEL INCREASED 3 0.0002
402 NECROSIS 1 0.0002
403 HAEMOPTYSIS 5 0.0002
404 ACUTE PULMONARY OEDEMA 1 0.0002
405 MITRAL VALVE INCOMPETENCE 2 0.0002
406 CHOLECYSTITIS ACUTE 1 0.0002
407 MYOCARDIAL ISCHAEMIA 2 0.0002
408 HAEMOGLOBIN DECREASED 18 0.0002
409 ENTEROCOLITIS 1 0.0002
410 PULMONARY EMBOLISM 16 0.0002
411 GANGRENE 1 0.0002
412 HEPATIC FAILURE 5 0.0002
413 CARDIOMEGALY 2 0.0002
414 CHOLANGITIS 1 0.0002
415 OLIGURIA 1 0.0002
416 ILEUS 2 0.0002
417 INFUSION SITE EXTRAVASATION 1 0.0002
418 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
419 HAEMOGLOBIN ABNORMAL 1 0.0002
420 HERPES SIMPLEX 1 0.0002
421 RESPIRATORY TRACT INFECTION 4 0.0002
422 PRODUCT PREPARATION ISSUE 1 0.0002
423 BEDRIDDEN 2 0.0002
424 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
425 BLOOD PRESSURE ABNORMAL 3 0.0002
426 EXPIRED PRODUCT ADMINISTERED 5 0.0002
427 HYPOTENSION 30 0.0001
428 POSTOPERATIVE WOUND INFECTION 1 0.0001
429 ULCER HAEMORRHAGE 1 0.0001
430 INFARCTION 1 0.0001
431 ECCHYMOSIS 1 0.0001
432 CORONARY ARTERY OCCLUSION 2 0.0001
433 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
434 BLINDNESS UNILATERAL 2 0.0001
435 DUODENAL ULCER 1 0.0001
436 DIVERTICULUM 1 0.0001
437 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
438 PRODUCT DISPENSING ERROR 3 0.0001
439 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
440 CARDIOMYOPATHY 2 0.0001
441 TROPONIN INCREASED 1 0.0001
442 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
443 DRUG ADMINISTRATION ERROR 4 0.0001
444 HAEMOLYSIS 1 0.0001
445 LYMPHOMA 2 0.0001
446 EJECTION FRACTION DECREASED 2 0.0001
447 PELVIC FRACTURE 1 0.0001
448 NERVOUS SYSTEM DISORDER 4 0.0001
449 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
450 PNEUMONIA 41 0.0001
451 PNEUMOTHORAX 2 0.0001
452 TRICUSPID VALVE INCOMPETENCE 1 0.0001
453 ANAEMIA 24 0.0001
454 ASPHYXIA 1 0.0001
455 POLYURIA 1 0.0001
456 ESCHERICHIA INFECTION 1 0.0001
457 URINARY RETENTION 4 0.0001
458 RENAL IMPAIRMENT 10 0.0001
459 SKIN PLAQUE 1 0.0001
460 FACIAL PARALYSIS 1 0.0001
461 PRODUCT CONTAINER ISSUE 1 0.0001
462 DELIRIUM 4 0.0001
463 URINE OUTPUT DECREASED 1 0.0001
464 HAEMARTHROSIS 1 0.0001
465 BLOOD BILIRUBIN INCREASED 3 0.0001
466 GASTROINTESTINAL CARCINOMA 1 0.0001
467 END STAGE RENAL DISEASE 2 0.0001
468 PNEUMONIA BACTERIAL 1 0.0001
469 RESPIRATORY ARREST 3 0.0001
470 RESPIRATORY DISTRESS 3 0.0001
471 OVARIAN CANCER 1 0.0001
472 HEPATIC FUNCTION ABNORMAL 4 0.0001
473 HEPATIC CIRRHOSIS 2 0.0001
474 PRODUCT PACKAGING ISSUE 1 0.0001
475 AFFECT LABILITY 1 0.0001
476 SINUS BRADYCARDIA 1 0.0001
477 SURGERY 6 0.0001
478 RESPIRATORY DISORDER 3 0.0001
479 DRUG LEVEL DECREASED 1 0.0001
480 EPILEPSY 3 0.0001
481 LUNG NEOPLASM MALIGNANT 4 0.0001
482 PETECHIAE 1 0.0001
483 ROAD TRAFFIC ACCIDENT 4 0.0001
484 DRUG INTERACTION 15 0.0001
485 METABOLIC ACIDOSIS 3 0.0001
486 DEEP VEIN THROMBOSIS 6 0.0001
487 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
488 OESOPHAGITIS 1 0.0001
489 HYPERTENSIVE CRISIS 1 0.0001
490 MALNUTRITION 1 0.0001
491 PULMONARY OEDEMA 4 0.0001
492 INTESTINAL PERFORATION 1 0.0001
493 PRODUCT PRESCRIBING ERROR 2 0.0001
494 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
495 INJECTION SITE EXTRAVASATION 1 0.0001
496 GENERALISED OEDEMA 1 0.0001
497 DYSARTHRIA 3 0.0001
498 GASTRIC CANCER 2 0.0001
499 CARDIOVASCULAR DISORDER 2 0.0001
500 MYDRIASIS 1 0.0001
501 ANAPHYLACTIC SHOCK 2 0.0001
502 SPEECH DISORDER 4 0.0001
503 SARS-COV-2 TEST POSITIVE 1 0.0001
504 SOPOR 1 0.0001
505 BLOOD PRESSURE DECREASED 5 0.0001
506 THROMBOSIS 6 0.0001
507 JAUNDICE 2 0.0001
508 ATRIAL FIBRILLATION 7 0.0001
509 DEVICE OCCLUSION 1 0.0001
510 BRONCHOSPASM 1 0.0001
511 PARALYSIS 1 0.0001
512 MYELODYSPLASTIC SYNDROME 1 0.0001
513 INFECTION 10 0.0001
514 HYPOKINESIA 1 0.0001
515 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
516 COLON CANCER 1 0.0001
517 CORONARY ARTERY DISEASE 2 0.0001
518 DRUG DISPENSING ERROR 1 0.0001
519 CYANOSIS 1 0.0001
520 PRODUCT USE COMPLAINT 1 0.0001
521 MYOCARDIAL INFARCTION 11 0.0001
522 SENSORY DISTURBANCE 1 0.0001
523 BLOOD CREATININE INCREASED 4 0.0001
524 METASTASES TO BONE 1 0.0001
525 VENTRICULAR TACHYCARDIA 1 0.0001
526 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
527 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
528 DEHYDRATION 8 0.0001
529 METRORRHAGIA 1 0.0001
530 EOSINOPHILIA 1 0.0001
531 HYPERKALAEMIA 2 0.0001
532 COLD SWEAT 1 0.0001
533 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
534 TACHYCARDIA 5 0.0001
535 CONDITION AGGRAVATED 17 0.0001
536 DRUG EFFECT DECREASED 3 0.0001
537 DRUG EFFECT INCOMPLETE 2 0.0001
538 INTESTINAL OBSTRUCTION 2 0.0001
539 BLOOD URINE PRESENT 1 0.0001
540 PROTEINURIA 1 0.0001
541 HAEMORRHOIDS 1 0.0001
542 KIDNEY INFECTION 1 0.0001
543 HAEMATOCRIT DECREASED 1 0.0001
544 PLEURAL EFFUSION 3 0.0000
545 RIB FRACTURE 1 0.0000
546 DRUG INEFFECTIVE 64 0.0000
547 RHABDOMYOLYSIS 2 0.0000
548 OVERDOSE 10 0.0000
549 ANGIOEDEMA 2 0.0000
550 LIVER DISORDER 2 0.0000
551 TRANSAMINASES INCREASED 1 0.0000
552 TOOTH DISORDER 1 0.0000
553 ABDOMINAL PAIN 10 0.0000
554 RENAL DISORDER 2 0.0000
555 INJURY 3 0.0000
556 HYPOGLYCAEMIA 2 0.0000
557 LIVER INJURY 1 0.0000
558 ENCEPHALOPATHY 1 0.0000
559 DRUG RESISTANCE 1 0.0000
560 GASTRITIS 1 0.0000
561 BRADYCARDIA 2 0.0000
562 PALLOR 1 0.0000
563 PNEUMONITIS 1 0.0000
564 SKIN LESION 1 0.0000
565 TREATMENT FAILURE 3 0.0000
566 ANAPHYLACTIC REACTION 2 0.0000
567 FALL 12 0.0000
568 PROCEDURAL PAIN 1 0.0000
569 THROMBOCYTOPENIA 4 0.0000
570 OXYGEN SATURATION DECREASED 2 0.0000
571 TOXICITY TO VARIOUS AGENTS 6 0.0000
572 RED BLOOD CELL COUNT DECREASED 1 0.0000
573 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
574 PANCREATIC CARCINOMA 1 0.0000
575 DYSSTASIA 1 0.0000
576 BLOOD POTASSIUM DECREASED 1 0.0000
577 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
578 THERAPEUTIC RESPONSE DECREASED 2 0.0000
579 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
580 CHEST PAIN 6 0.0000
581 FEMUR FRACTURE 1 0.0000
582 BONE DENSITY DECREASED 1 0.0000
583 LOSS OF CONSCIOUSNESS 4 0.0000
584 INTENTIONAL OVERDOSE 2 0.0000
585 CONTUSION 3 0.0000
586 MOVEMENT DISORDER 1 0.0000
587 STAPHYLOCOCCAL INFECTION 1 0.0000
588 LIP SWELLING 1 0.0000
589 ABDOMINAL DISCOMFORT 5 0.0000
590 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
591 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
592 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
593 HEART RATE DECREASED 1 0.0000
594 HYPOXIA 1 0.0000
595 HYPERTENSION 6 0.0000
596 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
597 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
598 RESTLESSNESS 1 0.0000
599 DYSPNOEA EXERTIONAL 1 0.0000
600 UNEVALUABLE EVENT 2 0.0000
601 MUSCULAR WEAKNESS 3 0.0000
602 COLITIS 1 0.0000
603 CHRONIC KIDNEY DISEASE 2 0.0000
604 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
605 VOMITING 12 0.0000
606 ABNORMAL BEHAVIOUR 1 0.0000
607 DISORIENTATION 1 0.0000
608 EXTRA DOSE ADMINISTERED 1 0.0000
609 DYSKINESIA 1 0.0000
610 URINARY TRACT INFECTION 4 0.0000
611 VAGINAL HAEMORRHAGE 1 0.0000
612 MENTAL DISORDER 1 0.0000
613 PRODUCT STORAGE ERROR 2 0.0000
614 THERAPY NON-RESPONDER 1 0.0000
615 NEPHROLITHIASIS 1 0.0000
616 HYPOKALAEMIA 1 0.0000
617 HYPERSENSITIVITY 4 0.0000
618 ARRHYTHMIA 1 0.0000
619 DYSPHAGIA 2 0.0000
620 LUNG DISORDER 1 0.0000
621 BLOOD PRESSURE INCREASED 3 0.0000
622 NERVOUSNESS 1 0.0000
623 PANCREATITIS 1 0.0000
624 OEDEMA 1 0.0000
625 HERPES ZOSTER 1 0.0000
626 PYREXIA 6 0.0000
627 COVID-19 3 0.0000
628 WHEEZING 1 0.0000
629 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
630 OFF LABEL USE 13 0.0000
631 DYSPNOEA 8 0.0000
632 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
633 CARDIAC FAILURE CONGESTIVE 1 0.0000
634 PROSTATE CANCER 1 0.0000
635 RASH 5 0.0000
636 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
637 GASTROINTESTINAL DISORDER 1 0.0000
638 ADVERSE DRUG REACTION 1 0.0000
639 ADVERSE EVENT 1 0.0000
640 SOMNOLENCE 2 0.0000
641 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
642 MALAISE 4 0.0000
643 SEIZURE 1 0.0000
644 DISEASE PROGRESSION 1 0.0000
645 ASTHENIA 3 0.0000
646 NAUSEA 6 0.0000
647 PRODUCT QUALITY ISSUE 1 0.0000
648 NEUTROPENIA 1 0.0000
649 DIARRHOEA 4 0.0000
650 CONFUSIONAL STATE 1 0.0000
651 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
652 NASOPHARYNGITIS 1 0.0000
653 PRODUCT USE ISSUE 1 0.0000
654 BLOOD GLUCOSE INCREASED 1 0.0000
655 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
656 ERYTHEMA 1 0.0000
657 HEADACHE 3 0.0000
658 CONSTIPATION 1 0.0000
659 INCORRECT DOSE ADMINISTERED 1 0.0000
660 ANXIETY 1 0.0000
661 ARTHRALGIA 1 0.0000
662 DIZZINESS 1 0.0000
663 PAIN 1 0.0000
664 FATIGUE 1 0.0000